Tealwood Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Buy |
2,372
+637
| +37% | +$334K | 0.55% | 96 |
|
|
2025
Q1 | $1.1M | Sell |
1,735
-5
| -0.3% | -$3.17K | 0.51% | 100 |
|
|
2024
Q4 | $1.24M | Buy |
1,740
+4
| +0.2% | +$2.85K | 0.51% | 97 |
|
|
2024
Q3 | $1.83M | Buy |
+1,736
| New | +$1.83M | 0.8% | 50 |
|
|
2024
Q2 | – | Sell |
-1,731
| Closed | -$1.67M | – | 99 |
|
|
2024
Q1 | $1.67M | Sell |
1,731
-17
| -1% | -$16.4K | 0.75% | 58 |
|
|
2023
Q4 | $1.54M | Sell |
1,748
-25
| -1% | -$22K | 0.73% | 60 |
|
|
2023
Q3 | $1.46M | Buy |
1,773
+32
| +2% | +$26.3K | 0.75% | 58 |
|
|
2023
Q2 | $1.25M | Sell |
1,741
-8
| -0.5% | -$5.75K | 0.61% | 80 |
|
|
2023
Q1 | $1.44M | Sell |
1,749
-679
| -28% | -$558K | 0.73% | 54 |
|
|
2022
Q4 | $1.75M | Sell |
2,428
-132
| -5% | -$95.2K | 0.92% | 31 |
|
|
2022
Q3 | $1.76M | Sell |
2,560
-36
| -1% | -$24.8K | 0.95% | 30 |
|
|
2022
Q2 | $1.54M | Sell |
2,596
-61
| -2% | -$36.1K | 0.76% | 42 |
|
|
2022
Q1 | $1.86M | Sell |
2,657
-29
| -1% | -$20.3K | 0.79% | 39 |
|
|
2021
Q4 | $1.7M | Sell |
2,686
-199
| -7% | -$126K | 0.68% | 60 |
|
|
2021
Q3 | $1.75M | Buy |
+2,885
| New | +$1.75M | 0.71% | 49 |
|
|
2021
Q1 | $1.1M | Buy |
2,321
+41
| +2% | +$19.4K | 0.44% | 109 |
|
|
2020
Q4 | $1.1M | Buy |
+2,280
| New | +$1.1M | 0.52% | 96 |
|